What is Kyndryl's share repurchase program and when was it authorized?

Kyndryl's share repurchase program was authorized in November 2024. In Q1 fiscal 2027, the company repurchased 5.0 million shares at a cost of $64 million. Cumulatively, since authorization, the company has repurchased 19.3 million shares for $462 million, representing 8% of its then-outstanding shares.

What was the average price paid per share in Q1 fiscal 2027?

Kyndryl repurchased 5.0 million shares for $64 million in Q1 fiscal 2027, resulting in an average price of $12.80 per share. This represents the execution average for the quarter only and does not reflect the blended average across the entire program period since November 2024.

How do the Q1 repurchases impact Kyndryl's share count?

The 5 million shares repurchased in Q1 contribute to the cumulative 19.3 million shares (8% of outstanding shares) retired under the program since November 2024. Weighted-average diluted shares outstanding declined to 220.6 million in Q1 fiscal 2027 from 239.1 million in the prior year, reflecting both the buyback activity and other factors including equity awards and shares-for-taxes payments.

Did Kyndryl disclose the total authorization amount or remaining capacity for repurchases?

No. The Q1 earnings release does not specify the total dollar authorization amount or the remaining available capacity under the November 2024 program. Investors would need to consult the company's earlier program announcement or SEC filings (such as a Form 8-K or proxy statement from November 2024) to determine these details.

What execution mechanism did Kyndryl use for the repurchases?

The Q1 earnings release does not specify whether the repurchases were conducted under Rule 10b-18 open-market purchases, an accelerated share repurchase agreement, a 10b5-1 plan, or another mechanism. This level of detail is typically disclosed in SEC Forms 8-K or 10-Q filings rather than press releases.

How sustainable are the buybacks given Kyndryl's current cash flow performance?

In Q1 fiscal 2027, Kyndryl reported negative free cash flow of $401 million and negative operating cash flow of $310 million, both significantly worse than the prior year. The $64 million in repurchases represents a modest 16% of the quarterly cash burn from operations. The company's ability to sustain or expand buyback activity will likely depend on improving operating performance and cash generation in future quarters.

KD 8-K Filed 2026-08-05 Execution disclosure

Kyndryl repurchased 5M shares at $12.80 in Q1 fiscal 2027

Company has now bought back 19.3M shares ($462M total) since November 2024 authorization

Shares repurchased5.0M

Avg price paid$12.80

MechanismNot specified

What the filing says

Kyndryl Holdings, Inc. (NYSE: KD) repurchased 5.0 million shares of common stock in the first quarter of fiscal year 2027 (ended June 30, 2026) at a total cost of $64 million, representing an average price of $12.80 per share. This quarterly repurchase activity is part of the company's broader share-repurchase program authorized in November 2024.

Since the program's authorization in November 2024, Kyndryl has repurchased a cumulative 19.3 million shares for $462 million, representing approximately 8% of shares outstanding at the time of the filing. The company did not disclose the total authorization amount, the specific execution mechanism (such as Rule 10b-18 open-market purchases or other method), or any remaining authorization balance in this earnings release.

The repurchase activity is disclosed in the company's cash flow statement, where common stock repurchases of $64 million appear under financing activities for the three-month period ended June 30, 2026. This represents part of the company's capital allocation strategy alongside its debt repayment activities and ongoing business investments.

In the first quarter, the Company repurchased 5.0 million shares of its common stock at a cost of $64 million. Since the authorization of its share repurchase program in November 2024, the Company has bought back 19.3 million shares for $462 million, or 8% of its shares outstanding. — Kyndryl Holdings, Inc. 8-K filing · View on SEC EDGAR →

What this means

Kyndryl's Q1 repurchase of 5 million shares represents an ongoing execution of its November 2024 program authorization. The cumulative 19.3 million shares repurchased (8% of outstanding shares) demonstrates material commitment to share count reduction, which can have positive mechanical effects on earnings-per-share metrics, though the company is currently reporting adjusted net losses in the quarter. The $64 million quarterly spend is modest relative to the company's $3.6 billion quarterly revenue base, suggesting the buyback is not a primary use of free cash flow. The company faces headwinds including a $69 million pretax loss and negative free cash flow of $401 million in the quarter, which may constrain future buyback activity absent improvement in operating cash generation.

Frequently asked questions

What is Kyndryl's share repurchase program and when was it authorized?: Kyndryl's share repurchase program was authorized in November 2024. In Q1 fiscal 2027, the company repurchased 5.0 million shares at a cost of $64 million. Cumulatively, since authorization, the company has repurchased 19.3 million shares for $462 million, representing 8% of its then-outstanding shares.
What was the average price paid per share in Q1 fiscal 2027?: Kyndryl repurchased 5.0 million shares for $64 million in Q1 fiscal 2027, resulting in an average price of $12.80 per share. This represents the execution average for the quarter only and does not reflect the blended average across the entire program period since November 2024.
How do the Q1 repurchases impact Kyndryl's share count?: The 5 million shares repurchased in Q1 contribute to the cumulative 19.3 million shares (8% of outstanding shares) retired under the program since November 2024. Weighted-average diluted shares outstanding declined to 220.6 million in Q1 fiscal 2027 from 239.1 million in the prior year, reflecting both the buyback activity and other factors including equity awards and shares-for-taxes payments.
Did Kyndryl disclose the total authorization amount or remaining capacity for repurchases?: No. The Q1 earnings release does not specify the total dollar authorization amount or the remaining available capacity under the November 2024 program. Investors would need to consult the company's earlier program announcement or SEC filings (such as a Form 8-K or proxy statement from November 2024) to determine these details.
What execution mechanism did Kyndryl use for the repurchases?: The Q1 earnings release does not specify whether the repurchases were conducted under Rule 10b-18 open-market purchases, an accelerated share repurchase agreement, a 10b5-1 plan, or another mechanism. This level of detail is typically disclosed in SEC Forms 8-K or 10-Q filings rather than press releases.
How sustainable are the buybacks given Kyndryl's current cash flow performance?: In Q1 fiscal 2027, Kyndryl reported negative free cash flow of $401 million and negative operating cash flow of $310 million, both significantly worse than the prior year. The $64 million in repurchases represents a modest 16% of the quarterly cash burn from operations. The company's ability to sustain or expand buyback activity will likely depend on improving operating performance and cash generation in future quarters.

execution fiscal-2027 q1-results share-reduction mid-cap

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.